Hepatic Angiosarcoma May Have Fair Survival Nowadays

Hepatic angiosarcoma (HAS) is rare but often fatal. A review of literature in 1979 found that only 3% of the 70 patients lived for more than 2 years, but the survival might have been improved over the years. We conducted a retrospective study and reviewed the medical records of patients who visited...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Neng-Chyan, Kuo, Yau-Chang, Chiang, Jui-Chin, Hung, Shih-Yuan, Wang, Huay-Min, Hung, Yao-Min, Chang, Yun-Te, Wann, Shue-Ren, Chang, Hong-Tai, Wang, Jyh-Seng, Ho, Sheng-Yow, Guo, How-Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602568/
https://www.ncbi.nlm.nih.gov/pubmed/25984668
http://dx.doi.org/10.1097/MD.0000000000000816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602568/
https://www.ncbi.nlm.nih.gov/pubmed/25984668
http://dx.doi.org/10.1097/MD.0000000000000816

Ejemplares similares